Kamel Addo, MD
NPI 1700864626 · Internal Medicine Physician · Columbus, OH
Enrolled with Medicare as Practitioner - Cardiac Electrophysiology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1700864626
- Entity type
- Individual
- Primary specialty
- Internal Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- MD11414 (RI)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,585 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Evaluation of Single, Dual, Multiple Lead Or Leadless Pacemaker System Or Implantable Defibrillator System, Remote Up to 90 Days93296 | 601 | $19 |
| Evaluation of Single, Dual, Multiple Lead Or Leadless Pacemaker System, Remote Up to 90 Days93294 | 410 | $28 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report93000 | 234 | $13 |
| Evaluation of Single, Dual, Or Multiple Lead Implantable Defibrillator System, Remote Up to 90 Days93295 | 192 | $35 |
| Evaluation of Cardiac Rhythm Monitor System, Remote Up to 30 Days93298 | 151 | $92 |
| Evaluation of Implantable Heart and Blood Vessel Monitoring System, Remote Up to 30 Days93297 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Apixabanbrand: Eliquis | 150 | 55 |
| Sotalol Hclbrand: Sotalol | 134 | 44 |
| Amiodarone Hcl | 132 | 43 |
| Metoprolol Succinate | 130 | 39 |
| Rivaroxabanbrand: Xarelto | 45 | 13 |
| Losartan Potassium | 34 | 12 |
| Lisinopril |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$5,166 across 88 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-03
- Last updated
- 2010-09-23
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.